Health & Nutrition

bg
Omada Health prices IPO at $19 per share, in middle of expected range

Omada Health prices IPO at $19 per share, in middle of...

Omada Health is set to start trading on the Nasdaq, hitting the market a few weeks...

bg
How twin sister triathletes doubled down on sports success to raise health-startup millions from investors

How twin sister triathletes doubled down on sports success...

Michal and Merav Mor, twin sister triathletes and PhDs, turned a quest for fitness...

bg
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

FDA approves Merck’s RSV shot for infants, ramping up competition...

Merck's shot will compete against a similar blockbuster treatment from Sanofi and...

bg
Omada shares rise 21% in Nasdaq debut after health tech company's IPO

Omada shares rise 21% in Nasdaq debut after health tech...

Omada Health became the latest tech company to hit the Nasdaq on Friday, as the...

bg
RFK Jr. removes all members of CDC panel advising U.S. on vaccines

RFK Jr. removes all members of CDC panel advising U.S....

It's the latest move by Kennedy – a prominent vaccine skeptic – to change and potentially...

bg
Chemical Safety, Cultivated Meat, and Our Health 

Chemical Safety, Cultivated Meat, and Our Health 

More than 95 percent of human exposure to industrial pollutants like dioxins and...

bg
Neuralink competitor Paradromics completes first human implant

Neuralink competitor Paradromics completes first human...

The procedure took place at the University of Michigan with a patient who was already...

bg
Hims & Hers to acquire European telehealth platform in global expansion

Hims & Hers to acquire European telehealth platform in...

Hims & Hers Health will acquire Zava, expanding the company's services to Ireland,...

bg
Elon Musk's Neuralink raises $650 million in fresh capital

Elon Musk's Neuralink raises $650 million in fresh capital

Neuralink is building a brain-computer interface, or BCI, which is a system that...

bg
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

Healthy Returns: AstraZeneca, Pfizer, Gilead and other...

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy...